Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report) shot up 0% on Friday . The company traded as high as $0.30 and last traded at $0.27. 87,235 shares traded hands during trading, an increase of 206% from the average session volume of 28,509 shares. The stock had previously closed at $0.27.
Revolution Medicines Stock Performance
The business has a fifty day simple moving average of $0.15 and a two-hundred day simple moving average of $0.15.
Revolution Medicines Company Profile
Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.
Featured Stories
- Five stocks we like better than Revolution Medicines
- How to Effectively Use the MarketBeat Ratings Screener
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- CD Calculator: Certificate of Deposit Calculator
- Overheated Market? Analysts Watch These Red Flags
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Revolution Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolution Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
